Immune System Therapeutics

About:

Immune System Therapeutics develops monoclonal antibody technologies for the treatment of blood cancers and other blood disorders.

Website: http://www.istl.com.au

Top Investors: Symbion Pty Limited

Description:

Immune System Therapeutics Ltd (IST) is an unlisted public company limited by shares which was incorporated in Australia in 2001. Their mission is to develop and commercialise Mab technology for the treatment of blood cancers and other blood disorders.

Total Funding Amount:

$700000

Headquarters Location:

Sydney, New South Wales, Australia

Founded Date:

2001-01-01

Contact Email:

info(AT)istl.com.au

Founders:

Number of Employees:

11-50

Last Funding Date:

2005-03-10

IPO Status:

Private

Industries: